webinar register page

Webinar banner
When Every Second Counts: Hyperacute MR Imaging
When every second — and every image — is vital for accurate diagnosis and treatment decisions, Swoop™ Portable MR Imaging System is nearby and ready to scan in less than 2 minutes. Wheel it to the patient’s bedside and plug it into a standard wall outlet.

MRI — the most powerful modality for diagnosing ischemic stroke — is immediately accessible without patient transport and is ideally suited in a hyperacute setting such as the Emergency Department for stroke mimics and wake-up stroke patients.

Following diagnosis, Swoop’s™ serial imaging capabilities provide ongoing insight for evaluating treatment efficacy over time. Without moving the patient.

Learning outcomes:
Understand hyperacute MR imaging as it relates to Hyperfine’s new portable MR technology. How does it work, what are its indications, what clinical evidence has been published for stroke application.

After understanding the technology behind this new bedside MR, discuss specific patient populations who can benefit most from hyperacute MR such as wake-up stroke and stroke mimic patients.

May 20, 2021 03:00 PM in Eastern Time (US and Canada)

* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Shahid Nimjee MD, PhD
@The Ohio State University, Wexner Medical Center
Dr. Shahid Nimjee is an Assistant Professor in the Departments of Neuroscience and Neurological Surgery at the Ohio State University Wexner Medical Center's Comprehensive Stroke Center. His clinical specialties include open and endovascular neurosurgery, and his research focuses on exploiting the properties of RNA biology to better diagnose and treat thromboembolic disease as it pertains to cerebrovascular neurosurgery. He has received the American Heart Association’s New Investigator Award and Duke University’s RNA Award for Research within the Department of Genetics. Dr. Nimjee’s current work centers on development of a novel and reversible drug to treat patients who present with acute ischemic stroke. Dr. Nimjee completed his M.D. and Ph.D. at Duke University School of Medicine. He then remained at Duke to complete a residency in neurological surgery and fellowship in endovascular/cerebrovascular neurosurgery.